Neurocrine Biosciences Market Cap

Neurocrine Biosciences has a market cap or net worth of €12.94 billion as of December 1, 2025. Its market cap has increased by 6.77% in one year.

Market Cap

12.94B

Enterprise Value

12.39B

Revenue

2.29B

Ranking

n/a

PE Ratio

35.47

Stock Price

€130.10

Market Cap Chart

Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 167.33M to 12.94B, an increase of 7,633.39%. That is a compound annual growth rate of 15.86%.

Market Cap History

Date	Market Cap	% Change
Nov 28, 2025	13.08B	-1.99%
Dec 31, 2024	13.35B	13.98%
Dec 29, 2023	11.71B	9.01%
Dec 30, 2022	10.74B	51.23%
Dec 31, 2021	7.10B	-2.95%
Dec 31, 2020	7.32B	-17.01%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	242.88B
Siemens Aktiengesellschaft	176.79B
Allianz SE	141.56B
Deutsche Telekom AG	132.19B
Siemens Energy AG	98.23B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	69.85B
Rheinmetall AG	67.93B
Deutsche Bank Aktiengesellschaft	58.37B

Market Cap Rankings